跳至主要内容
临床试验/CTRI/2016/08/007227
CTRI/2016/08/007227招募中未知

Prospective observational study to determine bleeding risk and platelet transfusion requirements in haematological malignancies.

Tata Memorial Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients between age 1 and 60 years presenting to TMH, Parel with de novo hematological malignancy (newly diagnosed and not having received chemotherapy outside) and who will be treated with curative intent.

排除标准

  • 1) Those will myelodysplastric syndromes.
  • 2) Those with secondary leukemias.
  • 3) Those who have received prior chemotherapy.

研究者

相似试验